Spermary Tablets

Spermary Tablets is an approved oral biochemical drug developed and manufactured by Beijing First Biochemical Pharmaceutical. Derived from animal testicular tissue (spermary extract), the product serves as an androgen-based therapy. It is primarily indicated for the treatment of impotence and exhibits systemic androgenic effects, including the promotion of growth, stimulation of hematopoietic cells to increase erythropoietin production, and enhancement of protein synthesis. The drug is formulated as 0.2g tablets and is contraindicated in pregnant women and prepubertal children due to the risk of hormonal interference, such as virilization in female fetuses or precocious puberty in males. It represents a specialized biochemical tissue-derived product within the developer's portfolio of biochemical medicines.

Brand names

Spermary Tablets

Other names

Testicular TabletsGāowán Piàn